Company intelligence / Profile preview

Agilera Pharma AS

Kjeller, Akershus, Norwayagilera.no ↗

Ownership: Private
Employees: ~140
Development stage: Commercial

Overview

Agilera is a leading global CDMO specializing in the development and commercial production of radiopharmaceuticals. The company has delivered over 600,000 therapeutic doses to more than 40 countries and supports clients from preclinical development through global distribution. It was established in 2023 as a spin-out from Norway’s Institute for Energy Technology and is being acquired by PharmaLogic Holdings Corp., further expanding its reach and capabilities.

Therapeutic areas: Oncology
Modalities: RadiopharmaceuticalSmall molecule
Industry: Contract Manufacturing Organization

Partnerships

Major pharmaceutical companies globallyPharmaLogic Holdings Corp.

Beyond the preview

Go deeper on Agilera Pharma AS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agilera Pharma AS.

Explore the full profile